Overall net revenue from sales in Q1 was $8.3 million, the company said. ・The company said that it now has funds to sustain itself till the second quarter of 2027. ・Total net revenue from sales of ...

The average one-year price target for Tonix Pharmaceuticals Holding (NasdaqGS:TNXP) has been revised to $55.42 / share. This ...

Reports Phase 1 Data And Plans Phase 2 Study For Lyme Disease Prevention Candidate. Tonix Pharmaceuticals (NASDAQ: TNXP) announced the presentation of Phase 1 data and plans for an adaptive Phase 2 ...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pricing of a $4.4 million registered direct offering.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) saw its shares decline Thursday morning after the company filed a Form S-3 with the U.S. Securities and Exchange Commission. What To Know: The filing ...

We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week’s Top Performers. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ...

View Tonix Pharmaceuticals Holding Corp. TNXP stock quote prices, financial information, real-time forecasts, and company news from CNN.

Today is a banner day for anyone who happened to hold Tonix Pharmaceuticals (NASDAQ:TNXP) stock over the weekend. Early this morning, Tonix disclosed an exclusive license with a drug developer which ...

Here’s a basic investment overview of two small-cap NASDAQ biotechs with 2025 PDUFAs: Tonix Pharmaceuticals (TNXP) and Crinetics Pharmaceuticals (CRNX).Mechanism: Sublingual formulation of ...

We recently published an article titled Micro-, Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands ...